Typical atrial flutter — chronic management & ablation
Cavotricuspid isthmus flutter · Cardiac
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Typical atrial flutter is a macro-re-entrant atrial tachycardia around the cavotricuspid isthmus producing sawtooth flutter waves, commonly at an atrial rate near 300 bpm with 2:1 conduction. Cavotricuspid isthmus ablation is highly effective and first-line for durable cure.
Red flags
- 1:1 atrioventricular conduction (very fast, unstable)
- Haemodynamic instability
- Flutter with pre-excitation
- Syncope
- Rate uncontrollable with medication
Assessment
Differential diagnosis
- Atrial fibrillation
- Atypical (left atrial) flutter
- Focal atrial tachycardia
- Sinus tachycardia
- AVNRT
- Multifocal atrial tachycardia
Investigations
- 12-lead ECG (negative sawtooth flutter waves in inferior leads)
- TTE for atrial size and LV function
- TSH, electrolytes
- Ambulatory monitor if paroxysmal
- Renal function to guide anticoagulation dosing
- Transoesophageal echo before cardioversion if not anticoagulated
Management
- Confirm typical flutter and estimate the conduction ratio
- Apply the same stroke-risk approach as AF: CHA2DS2-VASc and anticoagulation
- Start a DOAC unless contraindicated
- Achieve rate control with a beta-blocker or non-dihydropyridine CCB (often difficult)
- Arrange cardioversion (electrical or with ibutilide) with appropriate anticoagulation cover
- Refer for cavotricuspid isthmus ablation as first-line definitive therapy
- Screen for and manage co-existent atrial fibrillation
- Treat reversible triggers (thyroid disease, lung disease, alcohol)
- Continue anticoagulation after ablation based on stroke risk, not rhythm outcome
- Counsel that AF may still occur after successful flutter ablation
- Monitor for recurrence with ambulatory ECG
- Arrange electrophysiology follow-up
Drugs & doses
Apixaban 5 mg PO BD (dose-reduce per criteria) or alternative DOAC
Bisoprolol 2.5-10 mg PO OD for rate control
Diltiazem SR 180-360 mg PO daily if beta-blocker unsuitable
Ibutilide 1 mg IV over 10 min (pharmacological cardioversion, monitored)
Flecainide 50-150 mg PO BD only with AV-nodal blocker to prevent 1:1 conduction
Disposition
Electrophysiology referral for ablation; GP/cardiology for anticoagulation and rate control. Admit for 1:1 conduction or instability.
Complications & pitfalls
- Thromboembolic stroke
- Tachycardia-mediated cardiomyopathy
- 1:1 conduction if class Ic given without AV blockade
- Progression to atrial fibrillation
- Recurrence after ablation (low for typical flutter)
Exam pearls
- Rate control is often harder to achieve in flutter than in AF — favour rhythm control/ablation
- Cavotricuspid isthmus ablation has >90% long-term success for typical flutter
- Anticoagulation decisions mirror atrial fibrillation
- Never give flecainide alone — slowing the atrial rate can allow 1:1 AV conduction
- AF commonly coexists or follows, so continued monitoring is essential
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.